In a press release this Tuesday, Solvay and INEOS announced they had the go-ahead from the European Commission with regards to INOVYN, their joint venture in chlorovinyls. “The Commission has indeed endorsed the transfer of a number of industrial assets from INEOS to the International Chemical Investors Group (ICIG), a prerequisite for the final approval,” the two companies added.
INOVYN will have its headquarters in London and will display a pro forma turnover of over 3 billion euros with its 18 plants located in Belgium, France, Germany, Italy, Norway, Sweden and the United Kingdom. The transaction is expected to be completed by July 1st.
(Source: Belga)
